Skip to main content
. Author manuscript; available in PMC: 2016 Dec 17.
Published in final edited form as: Lancet. 2016 Nov 16;388(10062):2873–2884. doi: 10.1016/S0140-6736(16)31275-2

Figure 1. Trial profile.

Figure 1

LMTM=leuco-methylthioninium bis(hydromethanesulfonate. ARIA= amyloid related imaging abnormalities. *Missing patients in the modified intention-to-treat analysis did not have a post-baseline efficacy assessment.